Evogene Ltd. has announced its upcoming Annual General Meeting of Shareholders, scheduled for August 11, 2025, at its executive offices in Rehovot, Israel. Key proposals to be voted on include the re-election of current nominees and the election of the Company's CEO and President as a director, to serve until the next Annual General Meeting. The Board of Directors recommends voting in favor of these proposals. Shareholders are encouraged to submit their proxy votes promptly.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.